Virtual Medicinal Product (VMP)
-
Progesterone 25mg/1.119ml solution for injection vials
Name Details
Current Name
Progesterone 25mg/1.119ml solution for injection vials
|
Start Date
29-01-2014
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.119
- UDFS UOM
- ml
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular, Subcutaneous
- Form
- Solution for injection
- Ontology Form/Route
- solutioninjection.subcutaneous, solutioninjection.intramuscular
- Non-availability Indicator
- Actual Products not Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
G03DA04
BNF |
Current BNF
06040102
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
06040102
|
Start Date
29-08-2014
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
23948311000001106 |
29-01-2014 |
|
VMP Ingredients
VMP ingredients table
Progesterone |
Based on Ingredient Substance |
|
22.35 mg |
1 ml |
Name
Progesterone
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
22.35
Strength and UOM (Dmr)
1
Parent Products
-
VTM
Progesterone
-
VMP
(Current) Progesterone 25mg/1.119ml solution f...
Virtual Medicinal Product Pack (VMPP) Information